Sign inJoin waitlistJoin the waitlist

CS

Cole Sterling

Physician · Johns Hopkins School of Medicine

Credentials: · · · ·

History

Johns Hopkins School of Medicine
2022–Present

Medical Oncology
2019–2021
Internal Medicine
Johns Hopkins University School of Medicine
2017–2019
Johns Hopkins Univ Sch of Med
2013–2017

Research

TRBC1-targeting antibody-drug conjugates for the treatment of T cell cancers
Nature · 2024 · 35 citations
Endoscopic Endonasal Approach to Mesencephalic Cavernous Malformations
Case report · World Neurosurgery · 2016 · 24 citations
Harnessing the immune system after allogeneic stem cell transplant in acute myeloid leukemia
Review · American Journal of Hematology · 2020 · First of 2 authors · 22 citations

Sima Rozati
10 papers
NW
Nina Wagner-Johnston
8 papers
SP
Suman Paul
8 papers
EF
Ephraim Fuchs
7 papers
LS
Lode Swinnen
7 papers
RA
Richard Ambinder
7 papers
JM
Javier Meade
6 papers
CH
Carol Huff
5 papers
PI
Philip Imus
5 papers
AA
Alexander Ambinder
4 papers
AD
Amy DeZern
4 papers
Bert Vogelstein
4 papers

Clinical trials

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy
Principal investigator · Recruiting · Phase 2
National Cancer Institute (NCI)
2026–2027
RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis
Principal investigator · Terminated · Phase 1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
2022–2024
Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy
Site PI · Recruiting · Phase 3
Eastern Cooperative Oncology Group
2025–2075
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Site PI · Recruiting · Phase 2
SWOG Cancer Research Network
2023–2030